Noelyn M Kljavin

Author PubWeight™ 26.12^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.	Nat Immunol	2006	6.82
2	Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation.	Cancer Cell	2009	4.47
3	CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens.	Cell	2006	2.89
4	Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumors.	PLoS One	2009	2.07
5	Oncogenic ERBB3 mutations in human cancers.	Cancer Cell	2013	2.06
6	Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells.	J Immunol	2008	1.92
7	IL-27 promotes T cell-dependent colitis through multiple mechanisms.	J Exp Med	2010	1.54
8	Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selection.	Cancer Res	2009	1.41
9	IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells.	J Exp Med	2010	1.41
10	Disruption of PH-kinase domain interactions leads to oncogenic activation of AKT in human cancers.	Proc Natl Acad Sci U S A	2012	1.22
11	A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation.	Biochem J	2013	0.81